Electronic Patient‐Reported Health‐Related Quality of Life Trajectories in ICU Survivors: A Multicentre Pilot Study‐Within‐a‐Trial Protocol
Authors:
- Elisa Zoe BattistelliEBElisa Zoe Battistelli
- Benjamin Skov Kaas‐HansenBKBenjamin Skov Kaas‐Hansen
- Anders GranholmAGAnders Granholm
- Ronni Thermann Reitz PlovsingRPRonni Thermann Reitz Plovsing
- Bodil Steen RasmussenBRBodil Steen Rasmussen
- Anders PernerAPAnders Perner
- Maj‐Brit Nørregaard KjærMKMaj‐Brit Nørregaard Kjær
Open Access
- 29 September 2026
- journal article
- research article
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (10) , e70342
Abstract
Background: Patient‐important outcomes beyond mortality, particularly health‐related quality of life (HRQoL), are frequently used in intensive care unit (ICU) trials. However, HRQoL assessment remains challenging due to methodological complexities, including poorly defined recovery trajectories, lack of consensus on measurement instruments, complexity of statistical analysis, and missing data. Electronic patient‐reported outcomes (ePROs) may improve data collection and efficiency, though their feasibility in ICU survivors is uncertain. Methods: This protocol outlines a longitudinal, multicentre pilot study‐within‐a‐trial aimed at evaluating the feasibility of ePRO‐based HRQoL follow‐up and exploring a trajectory‐based approach to HRQoL characterisation after critical illness. We plan to enrol 100 participants already undergoing 180‐day HRQoL follow‐up in the Intensive Care Platform Trial (INCEPT) to complete monthly EQ‐5D‐5L surveys delivered by text messages from 6 to 12 months after randomisation. Feasibility outcomes include enrolment and response rate, time to completion, reminder‐dependency, attrition pattern, agreement between modes of collection, and accessibility. Agreement between telephone‐ and ePRO‐based assessments at 180 days will be evaluated at the group and at the individual level. Longitudinal EQ‐5D‐5L index values and visual analogue scale trajectories will be analysed using area‐under‐the‐curve methods based on linear interpolation. Scenario‐based sensitivity analyses will assess the potential impact of unobserved mortality among dropouts. Discussion: We hypothesise that ePRO‐based repeated assessments of HRQoL will support the goal of optimised data collection methods, while ensuring resources control. Moreover, identification of a candidate approach to HRQoL characterisation may shed light into the full recovery trajectory of ICU survivors and improve the interpretation and clinical relevance of HRQoL outcome assessments.Keywords
Funding Information
- Novo Nordisk Fonden (NNF23OC0085106)
- Grosserer Jakob Ehrenreich og Hustru Grete Ehrenreichs Fond
- Dagmar Marshalls Fond
- Danmarks Frie Forskningsfond (4308‐00210B)
- Trombosestichting Nederland (2025_04)
This publication has 23 references indexed in Scilit:
- Statistical Methods for Analyzing EQ-5D in Randomized Clinical Trials: A Systematic Literature ReviewValue in Health, 2025
- A Systematic Literature Review of Important and Meaningful Differences in the EQ-5D Index and Visual Analog Scale ScoresValue in Health, 2024
- The Ceiling Effects of EQ-5D-3L and 5L in General Population Health Surveys: A Systematic Review and Meta-AnalysisValue in Health, 2024
- Best Practices for the Electronic Implementation and Migration of Patient-Reported Outcome MeasuresValue in Health, 2023
- Patient-Important Outcomes Other Than Mortality in Contemporary ICU Trials: A Scoping ReviewCritical Care Medicine, 2022
- A structured methodology review showed analyses of functional outcomes are frequently limited to “survivors only” in trials enrolling patients at high risk of deathJournal of Clinical Epidemiology, 2021
- A Core Outcome Set for Research Evaluating Interventions to Prevent and/or Treat Delirium in Critically Ill Adults: An International Consensus Study (Del-COrS)Critical Care Medicine, 2021
- Methods for Analysing and Reporting EQ-5D Data2020
- Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation ProtocolValue in Health, 2019
- Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial ProtocolsJAMA, 2018